← All candidates
17 insider filings on record.
17 filings on record.
EOLSEvolus, Inc.
NasdaqGM · Healthcare · $529.72M
$7.91
-0.25% · Sep 15
17 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 3 sells◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$529.72M
Float
47.6M
72% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
27.4
Price / sales
1.7
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Stewart Brady
Bought $204.5K on Aug 15 — 30,000 sh @ $6.82, held direct, 34% of their stake.
0 of 1 position beat the S&P
Director
White Albert G III
Bought $189.0K on Jun 9 — 20,000 sh @ $9.45, held direct, 40% of their stake.
1 of 2 positions beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
12 more transactions on Pro →Context
Wall St
$15.00 avg target
+89.6% vs today · 6 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q2 '26−$0.02 act+$0.02
Q1 '26−$0.05 act+$0.07
Q4 '25$0.01 act−$0.02
Q3 '25−$0.15 act+$0.04
Coverage
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a BetZacks · 2w agoWall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to TradeZacks · 08-11Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ...GuruFocus.com · 08-06Evolus Q2 Earnings Call HighlightsMarketBeat · 08-06
The file stays open
17 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice